Report overview
Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers.
This report contains market size and forecasts of Antiulcerant Drugs in Global, including the following market information:
Global Antiulcerant Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antiulcerant Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Proton Pump Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiulcerant Drugs include Takeda Pharmaceutical, Eisai, Daewoong Pharmaceutical, Allergan, AstraZeneca plc, Valeant, Zydus and Shire, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiulcerant Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiulcerant Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antiulcerant Drugs Market Segment Percentages, by Type, 2021 (%)
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists
Global Antiulcerant Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antiulcerant Drugs Market Segment Percentages, by Application, 2021 (%)
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others
Global Antiulcerant Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antiulcerant Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiulcerant Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antiulcerant Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire
